Date  |
|
| Dec 04, 2018 |
Vivos Inc. to Treat Advanced Canine Patient for Soft Tissue Sarcoma with IsoPet® |
| Oct 26, 2018 |
Vivos Inc. Successfully Administers IsoPet® to a Second Dog for Canine Sarcoma at the University of Missouri |
| Oct 22, 2018 |
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference |
| Oct 10, 2018 |
Vivos, Inc. Completes Common Stock Equity Financing to Fund Roll Out of IsoPet™ and Eliminate Toxic Debt |
| Oct 02, 2018 |
Vivos Inc Signs Memorandum of Understanding with Private Veterinary Hospital as Pilot Clinic for Commercial IsoPet® Therapy |
| Sep 26, 2018 |
First Successful Treatment of Canine Sarcoma using IsoPet® to be Presented at Veterinary Cancer Society Conference |
| Sep 25, 2018 |
Amending and Replacing the Initial Press Release on George Sharp; Disregard the first release: |
| Sep 25, 2018 |
Vivos Inc Retains Well-Known Analyst, George Sharp, as Advisor - Updated |
| Sep 25, 2018 |
Vivos Inc Retains Well-Know OTC Markets Analyst, George Sharp, as Advisor |
| Sep 24, 2018 |
Vivos Inc Signs a Standstill Agreement with Debt Holders Designed to Halt the Toxic Selling and Eliminate the Secured Toxic Debt |